These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 10945615)

  • 1. Efficacious chemoprevention of primary prostate cancer by flutamide in an autochthonous transgenic model.
    Raghow S; Kuliyev E; Steakley M; Greenberg N; Steiner MS
    Cancer Res; 2000 Aug; 60(15):4093-7. PubMed ID: 10945615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model.
    Raghow S; Hooshdaran MZ; Katiyar S; Steiner MS
    Cancer Res; 2002 Mar; 62(5):1370-6. PubMed ID: 11888907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressive effects of antiandrogens, finasteride and flutamide on development of prostatic lesions in a transgenic rat model.
    Cho YM; Takahashi S; Asamoto M; Suzuki S; Tang M; Shirai T
    Prostate Cancer Prostatic Dis; 2007; 10(4):378-83. PubMed ID: 17457304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP).
    Mentor-Marcel R; Lamartiniere CA; Eltoum IE; Greenberg NM; Elgavish A
    Cancer Res; 2001 Sep; 61(18):6777-82. PubMed ID: 11559550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen-independent prostate cancer progression in the TRAMP model.
    Gingrich JR; Barrios RJ; Kattan MW; Nahm HS; Finegold MJ; Greenberg NM
    Cancer Res; 1997 Nov; 57(21):4687-91. PubMed ID: 9354422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice.
    Gupta S; Ahmad N; Marengo SR; MacLennan GT; Greenberg NM; Mukhtar H
    Cancer Res; 2000 Sep; 60(18):5125-33. PubMed ID: 11016639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
    Raina K; Blouin MJ; Singh RP; Majeed N; Deep G; Varghese L; Glodé LM; Greenberg NM; Hwang D; Cohen P; Pollak MN; Agarwal R
    Cancer Res; 2007 Nov; 67(22):11083-91. PubMed ID: 18006855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
    Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
    Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of prostate carcinogenesis in probasin/SV40 T antigen transgenic rats by raloxifene, an antiestrogen with anti-androgen action, but not nimesulide, a selective cyclooxygenase-2 inhibitor.
    Zeng Y; Yokohira M; Saoo K; Takeuchi H; Chen Y; Yamakawa K; Matsuda Y; Kakehi Y; Imaida K
    Carcinogenesis; 2005 Jun; 26(6):1109-16. PubMed ID: 15731164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chinese medicinal herb Scutellaria barbata modulates apoptosis and cell survival in murine and human prostate cancer cells and tumor development in TRAMP mice.
    Wong BY; Nguyen DL; Lin T; Wong HH; Cavalcante A; Greenberg NM; Hausted RP; Zheng J
    Eur J Cancer Prev; 2009 Aug; 18(4):331-41. PubMed ID: 19444125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
    Narayanan BA; Narayanan NK; Pittman B; Reddy BS
    Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lobe-specific lineages of carcinogenesis in the transgenic adenocarcinoma of mouse prostate and their responses to chemopreventive selenium.
    Wang L; Zhang J; Zhang Y; Nkhata K; Quealy E; Liao JD; Cleary MP; Lü J
    Prostate; 2011 Sep; 71(13):1429-40. PubMed ID: 21360561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the autochthonous transgenic adenocarcinoma of the mouse prostate (TRAMP) as a model to study effects of castration therapy.
    Wikström P; Lindahl C; Bergh A
    Prostate; 2005 Feb; 62(2):148-64. PubMed ID: 15389804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The G gamma / T-15 transgenic mouse model of androgen-independent prostate cancer: target cells of carcinogenesis and the effect of the vitamin D analogue EB 1089.
    Perez-Stable CM; Schwartz GG; Farinas A; Finegold M; Binderup L; Howard GA; Roos BA
    Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):555-63. PubMed ID: 12050097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse.
    Wechter WJ; Leipold DD; Murray ED; Quiggle D; McCracken JD; Barrios RS; Greenberg NM
    Cancer Res; 2000 Apr; 60(8):2203-8. PubMed ID: 10786685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
    Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R
    Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral grape seed extract inhibits prostate tumor growth and progression in TRAMP mice.
    Raina K; Singh RP; Agarwal R; Agarwal C
    Cancer Res; 2007 Jun; 67(12):5976-82. PubMed ID: 17575168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse model.
    Hsieh CL; Xie Z; Yu J; Martin WD; Datta MW; Wu GJ; Chung LW
    Prostate; 2007 May; 67(7):685-91. PubMed ID: 17342752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2 accelerates multistep prostate carcinogenesis in vivo.
    Bruckheimer EM; Brisbay S; Johnson DJ; Gingrich JR; Greenberg N; McDonnell TJ
    Oncogene; 2000 Nov; 19(46):5251-8. PubMed ID: 11077442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression pattern of mouse homolog of prostate-specific membrane antigen (FOLH1) in the transgenic adenocarcinoma of the mouse prostate model.
    Schmittgen TD; Zakrajsek BA; Hill RE; Liu Q; Reeves JJ; Axford PD; Singer MJ; Reed MW
    Prostate; 2003 Jun; 55(4):308-16. PubMed ID: 12712410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.